Richard Burr: “Do I have your commitment to provide this Committee with those performance metrics on a monthly basis?”

I always like to bring things back to the present because I have a tremendous amount of respect for all four of you.

Without Orrin, we wouldn't have a generic drug industry.

Nobody has worked harder on this issue, I think, on the Hill than I have.

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.